Clin2
NCT07764679Possibly a fitRecruiting

Brain scan to detect Alzheimer's plaques

Mild Cognitive Impairment (MCI)Alzheimer's Disease (AD)

Part of Mental health clinical trials.

This study tests a new PET brain scan that uses a special dye to show amyloid plaques, which are linked to Alzheimer's disease. It may help doctors see if your memory problems are caused by Alzheimer's or something else.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
400 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • You are 40 years or older.
  • You have normal memory, mild memory loss (MCI), or Alzheimer's disease.
  • You can have an MRI scan (no metal implants like pacemakers) and are not claustrophobic.
  • You have not had recent radiation exposure from other imaging tests.
  • You do not have serious or unstable medical conditions.
  • If you are of childbearing age, you must use effective birth control, not be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07758660Enrolling by invitation· Phase 2
Brain scan study for Alzheimer's research

This study uses brain scans (PET) to look at changes in the brain that may be related to memory problems or Alzheimer's disease. It aims to improve understanding of the disease and may help develop better treatments.

New York, New York
NCT07580703Recruiting· Phase 1
Brain Imaging Study for Memory and Thinking Changes

This study tests a new type of brain scan (called [18F]Flortaucipir PET) that may help detect early signs of Alzheimer's disease. Researchers want to make sure the scan is safe and works well in Chinese patients aged 50–85 with normal thinking, mild memory problems, or Alzheimer's disease.

Beijing, Beijing Municipality
NCT07169630Recruiting· Phase 1
PET scan study for Alzheimer's or mild cognitive impairment

This study uses a special PET scan to look at a brain protein called PDE4 in people with Alzheimer's disease or mild cognitive impairment. It may help researchers understand how this protein is involved in memory and thinking problems.

Bethesda, Maryland
NCT07422857Recruiting· Phase 3
A PET scan for detecting signs of Alzheimer's

This trial uses a new type of PET scan to look for specific proteins in the brain that are linked to Alzheimer's disease. It will help doctors see how these proteins relate to cognitive decline and compare scans from people with normal thinking to those with memory problems.

Wuhan, Hubei
NCT00950430Enrolling by invitation· Phase 4
Brain scan study for amyloid plaques in adults

This study uses brain imaging to look for amyloid plaques (abnormal protein deposits) as people age. It may help researchers better understand how these changes develop over time.

Rochester, Minnesota
NCT07611357Not yet recruiting· Phase 2
Brain Imaging Study for Alzheimer's Disease Diagnosis

This study tests a new type of brain scan ([18F]F-AraG PET) that may help detect Alzheimer's disease earlier or more accurately. Researchers will take pictures of your brain to see if this scan can identify changes related to Alzheimer's.

Hear when a new Alzheimer's Disease (AD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.